← Back to Search

Procedure

Tx Axillary Hyperhidrosis 1210nm Diode Laser

N/A
Waitlist Available
Led By John P. Trafeli, MD
Research Sponsored by United States Naval Medical Center, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a new laser treatment for people who sweat excessively in their underarms. The laser heats specific tissues to reduce sweat production. The goal is to find a safe and effective alternative to current treatments. The Nd:YAG laser has been used in previous studies as a safe and effective option for treating excessive underarm sweating.

Eligible Conditions
  • Excessive Underarm Sweating

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
gravimetric analysis
modified starch-iodine test
subjective global assessment questionnaire

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: 1210nm laser treatments to the axillaExperimental Treatment1 Intervention
two laser treatments left axilla and one treatment right axilla
Group II: 1210nm axillary laser treatmentsExperimental Treatment1 Intervention
two laser treatments right axilla and one treatment left axilla

Find a Location

Who is running the clinical trial?

Candela Corp.UNKNOWN
United States Naval Medical Center, San DiegoLead Sponsor
108 Previous Clinical Trials
23,141 Total Patients Enrolled
John P. Trafeli, MDPrincipal InvestigatorUnited States Naval Medical Center, San Diego
~1 spots leftby Dec 2025